Safety and Efficacy Study of CAL-101 in Patients With Previously Treated Low-grade Lymphoma

This study is currently recruiting participants.
Verified November 2012 by Gilead Sciences
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT01306643
First received: February 25, 2011
Last updated: November 28, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)